Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × Radiosurgery × Clear all

NCT05626569 2024-01-03

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Phase 2 Unknown

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02545751 2017-11-28

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms